Naproxen sodium

Revision as of 18:15, 27 September 2011 by WikiBot (talk | contribs) (Protected "Naproxen": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Aleve, Anaprox, Bonyl, DL Naproxen, DL-Naproxen, Diocodal, Dysmenalgit, Ec-naprosyn, Equiproxen, Floginax, Laraflex, Laser, Mnpa, Naixan, Naprelan, Napren, Naprium, Naprius, Naprosine, Naprosyn, Naprosyne, Naproxen Sodium, Naprux, Naxen, Naxyn, Niaxan, Nycopren, Panoxen, Pranoxen, Prexan, Proxen, Proxine, Reuxen, Veradol, Xenar x

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Geriatric Patients
Studies indicate that although total plasma concentration of Naproxen is unchanged, the unbound plasma fraction of Naproxen is increased in the elderly. Caution is advised when high doses are required and some adjustment of dosage may be required in elderly patients. As with other drugs used in the elderly, it is prudent to use the lowest effective dose.

Patients with Moderate to Severe Renal Impairment
Naproxen-containing products are not recommended for use in patients with moderate to severe and severe renal impairment (creatinine clearance < 30 mL/min).

Rheumatoid Arthritis, Osteoarthritis and Ankylosing Spondylitis

  • 275 mg (Naproxen 250 mg with 25 mg sodium) twice daily
  • or 550 mg (Naproxen 500 mg with 50 mg sodium) twice daily


For more information on dosing please refer to Instructions for administration



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Naproxen sodium

Return to top

Publication Resources

Most Recent Articles on Naproxen sodium

Review Articles on Naproxen sodium

Articles on Naproxen sodium in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Naproxen sodium

Return to top

Trial Resources

Ongoing Trials with Naproxen sodium at Clinical Trials.gov

Trial Results with Naproxen sodium

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Naproxen sodium

Cochrane Collaboration on Naproxen sodium

Cost Effectiveness of Naproxen sodium

Return to top

Media Resources

Powerpoint Slides on Naproxen sodium

Images of Naproxen sodium

Podcasts & MP3s on Naproxen sodium

Videos on Naproxen sodium

Return to top

Patient Resources

Patient Resources on Naproxen sodium

Discussion Groups on Naproxen sodium

Patient Handouts on Naproxen sodium

Blogs on Naproxen sodium

Naproxen sodium in the News

Naproxen sodium in the Marketplace

Return to top

International Resources

Naproxen sodium en Español

Return to top


Adapted from the FDA Package Insert.